These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9243519)

  • 21. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents.
    Pierson ME; Comstock JM; Simmons RD; Kaiser F; Julien R; Zongrone J; Rosamond JD
    J Med Chem; 1997 Dec; 40(26):4302-7. PubMed ID: 9435899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
    Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
    J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
    Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
    Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel CCK-B receptor agonists: diketopiperazine analogues derived for CCK4 bioactive conformation.
    Weng JH; Bado A; Garbay C; Roques BP
    Regul Pept; 1996 Aug; 65(1):3-9. PubMed ID: 8876029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A further analysis of the contraction induced by activation of cholecystokinin A receptors in guinea pig isolated ileum longitudinal muscle-myenteric plexus.
    Corsi M; Palea S; Pietra C; Oliosi B; Gaviraghi G; Sugg E; Van Amsterdam FT; Trist DG
    J Pharmacol Exp Ther; 1994 Aug; 270(2):734-40. PubMed ID: 7520941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.
    Goudreau N; Weng JH; Roques BP
    Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
    Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
    J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-resistant CCK analogs with high affinities for central receptors.
    Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
    Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Tufano MD; Bianchi BR; Miller TR; Witte DG; Nadzan AM
    J Med Chem; 1991 Sep; 34(9):2837-42. PubMed ID: 1716682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of cholecystokinin on neurons in rat substantia nigra pars reticulata.
    Zhang J; Freeman AS
    Brain Res; 1994 Jul; 652(1):154-6. PubMed ID: 7953713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics.
    Goudreau N; Weng JH; Roques BP
    Arch Pharm (Weinheim); 1996 Apr; 329(4):197-204. PubMed ID: 8669984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs.
    Ebenezer IS; Parrott RF; Goode JA
    Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog.
    Simmons RD; Kaiser FC; Pierson ME; Rosamond JR
    Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin-induced activity changes of dorsal lateral geniculate neurons in rats.
    Albrecht D; Müller R; Zippel U; Gabriel HJ; Henklein P; Davidowa H
    Neuroscience; 1994 Apr; 59(4):953-60. PubMed ID: 8058128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
    Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
    Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.
    Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.